Morphosys Ag Asset Turnover Ratio (MOR), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Morphosys Ag  (NASDAQ: MOR)
 

Morphosys Ag Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Morphosys Ag's asset turnover ratio, the ratio that measures the ability of Morphosys Ag's assets to generate revenue, sequentially decreased to 0.12 in the fourth quarter (Dec 31 2023), which does not come as a surprise, as the Morphosys Ag continue to experience difficult business climate.

Within sector 183 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 2353 to 3482.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MOR Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -15.46 % -15.46 % -15.46 % -15.46 % -6.23 %
Y / Y Revenue Change -14.37 % - - - 54.93 %
Asset Turnover Ratio (TTM) 0.12 - - - 0.12
MOR's Total Ranking # 3482 # 2353 # 3403 # 0 # 2962
Seq. Asset Change 0 % 0 % 0 % -15.46 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 184
Healthcare Sector # 502
Overall Market # 3482

Asset Turnover Ratio Statistics
High Average Low
0.2 0.13 0.07
(Dec 31 2020)   (Dec 31 2021)




MOR Company Profile • Back to MOR Efficiency Comparisons • Compare MOR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Deciphera Pharmaceuticals Inc   0.32 $ 163.356  Millions$ 507.510  Millions
Collplant Biotechnologies Ltd  0.32 $ 10.959  Millions$ 34.126  Millions
Alcon inc   0.32 $ 9,455.000  Millions$ 29,512.750  Millions
Ultragenyx Pharmaceutical Inc   0.32 $ 434.249  Millions$ 1,355.967  Millions
Viatris Inc   0.32 $ 15,426.900  Millions$ 48,603.375  Millions
Veracyte Inc   0.32 $ 361.051  Millions$ 1,139.521  Millions
Yubo International Biotech Limited  0.32 $ 0.605  Millions$ 1.912  Millions
Marker Therapeutics inc   0.31 $ 6.811  Millions$ 21.628  Millions
The Cooper Companies Inc   0.31 $ 3,666.000  Millions$ 11,732.075  Millions
Qiagen N v   0.31 $ 1,900.688  Millions$ 6,115.190  Millions
Amgen Inc   0.31 $ 28,190.000  Millions$ 91,669.250  Millions
23andme Holding Co  0.31 $ 246.722  Millions$ 805.810  Millions
Kyntra Bio Inc   0.31 $ 147.752  Millions$ 484.406  Millions
Standard Biotools Inc   0.30 $ 105.450  Millions$ 347.458  Millions
Ss Innovations International Inc  0.30 $ 5.875  Millions$ 19.392  Millions
Personalis Inc   0.30 $ 73.481  Millions$ 243.238  Millions
Vanda Pharmaceuticals Inc   0.30 $ 192.640  Millions$ 644.065  Millions
Avid Bioservices Inc   0.30 $ 134.831  Millions$ 451.321  Millions
Elanco Animal Health Incorporated  0.29 $ 4,417.000  Millions$ 15,067.750  Millions
Mangoceuticals Inc   0.29 $ 0.731  Millions$ 2.515  Millions
Quanterix Corporation  0.29 $ 122.224  Millions$ 428.533  Millions
Redhill Biopharma Ltd   0.28 $ 6.530  Millions$ 23.047  Millions
Olink Holding Ab publ   0.28 $ 169.461  Millions$ 602.252  Millions
Dyadic International Inc   0.28 $ 2.899  Millions$ 10.340  Millions
Beam Therapeutics Inc   0.28 $ 377.709  Millions$ 1,359.122  Millions
Precision Biosciences Inc  0.27 $ 48.727  Millions$ 177.581  Millions
Pfizer Inc  0.27 $ 58,496.000  Millions$ 214,326.750  Millions
Innoviva Inc   0.27 $ 315.267  Millions$ 1,169.905  Millions
Alpha Teknova Inc   0.27 $ 36.296  Millions$ 135.135  Millions
Bioaffinity Technologies Inc   0.27 $ 2.532  Millions$ 9.437  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.